Overview
• The Colton Foundation has announced a new $15 million investment over three years in the Colton Consortium for Autoimmunity.
• The funding will support faculty recruitment, collaborative research projects, and shared research infrastructure.
• Tel Aviv University is one of the consortium's core partners, alongside leading institutions in the United States.
• The investment aims to accelerate breakthroughs in the understanding, diagnosis, and treatment of autoimmune diseases.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
